-
PROVIDERS
REGISTER NOW
What’s Next in Oncology: Research Breakthroughs from the 2025 ASCO® Annual Meeting
Tuesday, August 12th
11:00am PT, 1:00pm CT, 2:00pm ET -
LIFE SCIENCES
READ NOW
Q&A: Harnessing generative AI to refine clinical research & drug development
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Enhance your clinical development process with Tempus’ CDx platform
Learn how A2 Biotherapeutics is making progress on a breakthrough cell therapy using HLA-LOH (human leukocyte antigen-loss of heterozygosity) as a biomarker, using Tempus’ comprehensive immunotherapy platform.
-
07/29/2025Navigating New Frontiers in Breast Cancer Care Gap Closure: The Role of Providers and AI
Learn how AI and care pathway intelligence are transforming breast cancer care, featuring insights from providers at Mercy Health System. Discover how Tempus Next harnesses AI to integrate multimodal clinical data with up-to-date guidelines, supporting personalized care and the identification of potential care gaps. Secure your recording now.
Watch replay -
07/14/2025Closing Care Gaps with AI: The Next Competitive Edge in Pharma
Discover how Tempus is equipping life sciences teams with innovative AI and data analytics strategies to fully leverage their understanding of therapy trends, provider practices, and patient care. Secure your recording now.
Watch replay -
07/01/2025Transforming R&D with Generative AI and Real-World Data
Ryan Fukushima, Chief Operating Officer at Tempus, and Robert Shoemaker, Ph.D., Senior Vice President of Research at Erasca, Inc., spoke about the transformative power of artificial intelligence in oncology research and drug development at the AACR Annual Meeting 2025.
Watch now